CXCL8 and urinary bladder cancer: In summary, TAM-derived CXCL8 can promote the expression of MMP-9, VEGF, and E-cadherin in bladder cancer cells, causing changes in bladder cancer cell migration, invasion, and pro-angiogenic ability, and leading to the progression of bladder cancer.